Mirvetuxumab soravansine in combination with pegylated liposomal doxorubicin in adults with folate receptor alpha positive primary peritoneal cancer [53] Intraperitoneal delivery of paclitaxel [54]. This evidence concerns the gene FOLR1 and peritoneum cancer.